Ifosfamide in Thymic Neoplasms

Publisher： Karger

E-ISSN： 1423-0232|65|2|44-45

ISSN： 0030-2414

Source： Oncology, Vol.65, Iss.2, 2003-11, pp. : 44-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology of Ifosfamide

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 2-6

Karger

Access to resources Recommend Favorite

Side Effects of Ifosfamide

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 7-10

Karger

Access to resources Recommend Favorite

Neurological Toxicity of Ifosfamide

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 11-16

Karger

Access to resources Recommend Favorite

Ifosfamide and Cyclophosphamide: Effects on Immunosurveillance

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 17-20

Karger

Access to resources Recommend Favorite

Ifosfamide in Pediatric Solid Tumors

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 99-104

Karger

Access to resources Recommend Favorite